Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | N/A | 0 | 0 | 24,800 |
| Other current assets | 0 | 0 | 0 | 0 | 1,060 |
| TOTAL | $0 | $N/A | $0 | $0 | $25,860 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 1,050 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $1,050 |
| Total Assets | $0 | $N/A | $0 | $0 | $26,910 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 1,480 |
| Accrued Expenses | 0 | N/A | 0 | 0 | 2,730 |
| TOTAL | $0 | $N/A | $0 | $0 | $4,210 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $0 | $N/A | $0 | $0 | $4,210 |
| Shareholders' Equity | |||||
| Common Shares | 0 | N/A | 0 | 0 | 4 |
| Retained earnings | 0 | N/A | 0 | 0 | -25,330 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 26 |
| TOTAL | $0 | $N/A | $0 | $0 | $22,690 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $26,900 |